The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Normalization of Information Processing Deficits in Schizophrenia With Clozapine
Abstract
OBJECTIVE: The authors tested the hypothesis that the use of an atypical drug, clozapine, for patients with schizophrenia is related to less impairment in information processing deficits (assessed by prepulse inhibition of the startle response) than is the use of typical antipsychotics. METHOD: Two groups of schizophrenic patients--receiving either clozapine or a range of typical antipsychotics--were tested for prepulse inhibition (a reduction in response to a starting stimulus, if preceded briefly by a weak, nonstartling stimulus; measured at prepulse-to-pulse intervals of 30 msec, 60 msec, and 120 msec) of the acoustic startle response and compared with a group of healthy volunteers. RESULTS: Patients receiving typical antipsychotics showed less prepulse inhibition with 30-msec and 60-msec prepulse trials than did comparison subjects. Clozapine-treated patients showed normal levels of prepulse inhibition. CONCLUSIONS: Clozapine is superior to typical antipsychotics in normalizing prepulse inhibition, presumably because of its pharmacological effects on prefrontal regions of the brain or its effects on a broader range of neuroreceptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Cited by
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches
Franken, I. H. A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00081-2 · Cited by 763
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., Olincy, A., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 567
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529
Sensorimotor Gating in Larval Zebrafish
Burgess, H. A., & Granato, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0615-07.2007 · Cited by 518
Swerdlow, N. R., Braff, D. L., & Geyer, M. A. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200006000-00002 · Cited by 394
Greenwood, T. A., Braff, D. L., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. E., Gur, R. C., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1242 · Cited by 381
Swerdlow, N. R., Light, G. A., Cadenhead, K. S., Sprock, J., Hsieh, M. H., & Braff, D. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1325 · Cited by 339
Borrell, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00360-8 · Cited by 307
Prepulse inhibition in psychiatric disorders – Apart from schizophrenia
Kohl, S., Heekeren, K., Klosterkötter, J., & Kuhn, J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.11.018 · Cited by 298
Reavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., et al. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39184-0 · Cited by 287
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia
Braff, D. L., Geyer, M. A., Light, G. A., Sprock, J., Perry, W., Cadenhead, K. S., & Swerdlow, N. R. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00139-0 · Cited by 287
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania
Perry, W., Minassian, A., Feifel, D., & Braff, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01184-2 · Cited by 258
Endophenotypes in schizophrenia: A selective review
Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A., & Pearlson, G. D. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.016 · Cited by 210
“…al., 1999; K. Cadenhead et al., 1996; Cadenhead et al., 1993; Cadenhead et al., 2000; Dawson et al., 2000; Hong et al., 2007; Kumari et al., 2000; Kumari et al., 1999; Mackeprang et al., 2002; McDowd et al., 1993; Oranje et al., 2002; Parwani et al., 2000; Perry et al., 2002; Weike et al., 2000).”
The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
Geyer, M. A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033358 · Cited by 159
Neurological sequelae resulting from encephalitic alphavirus infection
Ronca, S. E., Dineley, K. T., & Paessler, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00959 · Cited by 157
Modulating sensory gating in healthy volunteers
Oranje, B., Gispen-de Wied, C. C., Verbaten, M. N., & Kahn, R. S. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01377-x · Cited by 98
Perineuronal nets and schizophrenia: The importance of neuronal coatings
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.018 · Cited by 95
Braff, D. L., Light, G. A., & Swerdlow, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.015 · Cited by 90
An Overview of the Association between Schizotypy and Dopamine
Mohr, C., & Ettinger, U. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00184 · Cited by 63
Powell, S. B., Young, J. W., Ong, J. C., Caron, M. G., & Geyer, M. A. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc110 · Cited by 57
“Atypical antipsychotics may be more effective at normalizing PPI deficits in patients with schizophrenia than are typical antipsychotics (Kumari et al., 1999).”
BackgroundIncreasing Dopaminergic Activity: Effects of L-Dopa and Bromocriptine on Human Sensory Gating
Oranje, B., Gispen-de Wied, C. C., Westenberg, H. G. M., Kemner, C., Verbaten, M. N., & Kahn, R. S. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800310 · Cited by 27
Mouse model of neurological complications resulting from encephalitic alphavirus infection
Ronca, S. E., Smith, J., Koma, T., Miller, M. M., Yun, N., Dineley, K. T., & Paessler, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00188 · Cited by 22
Metadata
- Authors
- Kumari, V., Soni, W., & Sharma, T.
- Venue
- American Journal of Psychiatry
- Published
- 1999-07-01
- Volume
- 156
- Issue
- 7
- Pages
- 1046-1051
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2167982093
- Cited by
- 243
- References
- 2
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.